ClinicalTrials.gg
CompletedNCT07938970Updated Nov 16, 2026

The Effects of Therapeutic Play on Fear and Anxiety Before Ultrasound Examinations in Children Aged 6-12

An interventional study of Therapeutic play in Child and Mother, sponsored by Firat University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Firat University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Aug 2025, registered Nov 2026).
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study was conducted to evaluate the effects of therapeutic play on fear and anxiety levels in children before ultrasound examinations. This controlled pretest-posttest study was conducted in the pediatric clinic of a city hospital between September 2025 and February 2026. The study was completed with 60 children aged 6-12 years (study group = 30, control group = 30). Data were collected using the Demographic Information Form, Children's Fear Scale, and Children's Anxiety Scale-State Anxiety. The study group received therapeutic play using handmade amigurumi materials before the ultrasound examination, while the control group received routine care.

Read the detailed description

Children in the study group received a therapeutic play intervention before their ultrasound examination. Before the intervention, the primary researcher provided parents with standard information about the purpose, process, and steps of the ultrasound examination.

A doll and a toy ultrasound machine made using the amigurumi technique were used during the therapeutic play session. Amigurumi is a traditional Japanese craft technique involving the creation of small, three-dimensional toys, dolls, and figures by crocheting or knitting yarn, typically using a crochet hook. In this study, the amigurumi materials were designed to represent a doll and an ultrasound machine for use in therapeutic play. First, the researcher explained the purpose of the ultrasound examination, how it is performed, and the body areas to be examined using age-appropriate and understandable language. This briefing lasted approximately 10 minutes.

Next, children were given the opportunity to examine the therapeutic play materials, touch them, and interact with them freely. This phase lasted approximately 15-20 minutes and aimed to familiarize children with the materials and the steps of the ultrasound procedure.

Subsequently, under the researcher's guidance, children simulated an ultrasound examination on the doll using the toy ultrasound device. Their active participation was encouraged, and they were given opportunities to express their feelings and thoughts about the procedure and ask questions. The emotional sharing and question-and-answer session lasted approximately 5 minutes.

Parents remained with their children throughout the intervention. After the therapeutic play session, children underwent the ultrasound examination accompanied by their parents. The parent's presence during the examination was determined through a joint decision involving the child, parent, and physician performing the ultrasound.

To ensure standardization, all interventions were conducted by the same researcher, using the same materials and following a predetermined intervention protocol. Intervention fidelity was assessed after each session using a standardized checklist, and adherence to the protocol was documented. The detailed therapeutic play protocol and intervention fidelity checklist are provided in Supplementary Material 1. Picture 1 presents the therapeutic play activity and the amigurumi materials used during the intervention.

Interventions in the Control Group Children and parents in the control group received standard information from the primary researcher before the ultrasound examination as part of the informed consent process. The purpose of the ultrasound examination, how it would be performed, and the areas to be evaluated were explained using simple and understandable language. No therapeutic play or additional intervention was provided.

Following this briefing, children underwent ultrasound examinations accompanied by their parents as part of routine clinical practice. The parent's presence during the procedure was determined through a joint decision involving the child, parent, and attending physician.

After completion of the research data collection, children and parents in the control group were informed about the amigurumi therapeutic play materials in accordance with ethical principles. Children who wished to participate (n = 20) were given the opportunity to become familiar with the materials and engage in therapeutic play. The ultrasound examination procedure was also demonstrated through play. This activity took place only after data collection had been completed and therefore did not affect the study results. Data collection was carried out by the primary researcher and one nurse evaluator. The same nurse evaluator conducted assessments for all children in both the study and control groups throughout the study. Before data collection began, the primary researcher provided the nurse evaluator with standardized training on the study procedures, data collection process, and administration of the measurement instruments. The nurse evaluator was responsible solely for assessing the children's fear and anxiety and did not participate in the therapeutic play intervention.

The primary researcher was a nurse receiving postgraduate education in pediatric nursing and had completed certified training in therapeutic play. She had approximately three years of work experience in pediatric clinics. Her responsibilities included coordinating the study, obtaining informed consent, conducting baseline and post-intervention assessments, and implementing the therapeutic play intervention in the study group. She did not participate in the delivery of routine clinical care.

Parents were present with their children throughout the therapeutic play intervention and during the ultrasound examination. They also independently rated their children's fear and anxiety.

Assessment Procedures and Data Collection Workflow Before the intervention, the study procedures and data collection tools were explained to the children, their parents, and the nurse evaluator. Written informed consent was obtained from the parents before the ultrasound examination.

At baseline, children independently completed the Children's Fear Scale (CFS) and the Children's Anxiety Scale-State (CAS-S) to report their own levels of fear and anxiety. In addition, the parent, nurse evaluator, and primary researcher independently rated each child's observed fear and anxiety using the same visual scales. Each assessor completed the ratings independently, without influencing the child's responses or the ratings of the other assessors.

Following the baseline assessments, the primary researcher administered the therapeutic play intervention to children in the study group, whereas children in the control group received routine care. All children subsequently underwent an ultrasound examination lasting approximately 5-10 minutes.

02

Conditions studied

  • Child
  • Mother

Browse trials for

Keywords

  • Therapeutic play
  • child
  • fear
  • anxiety
03

In context

Anxiety Disorders Unverified

7,231 studies on the registry are indexed under Anxiety Disorders; 1,686 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 6,085 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Firat University is the lead sponsor of 119 studies on the registry; 46 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - For children:
  • Being between 6 and 12 years of age.
  • Being accompanied by a parent.
  • Being able to communicate in Turkish.
  • Having no allergy to chemical dyes, according to parental reports.
  • Having no mental or physical disabilities.
  • Having no history of chronic nebulizer use.

For parents:

  • Being able to communicate in Turkish.
  • Being literate.
  • Having no mental or physical disabilities.

Exclusion criteria

Exclusion Criteria:

  • - For children:
  • Failing to complete the finger-painting intervention.
  • Having previously participated in a finger-painting intervention.
  • Having motor or functional impairments affecting the hands or fingers.

For parents:

- Having a mental health issue.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Therapeutic play is an effective intervention for reducing children's fear and anxiety levels during

    Ultrasonography is a safe diagnostic method widely used in children. However, the setting of the procedure and a sense of uncertainty can cause fear and anxiety in children. Therapeutic play is an effective intervention that supports children's compliance with medical procedures.

    Other: Therapeutic play

Interventions

  • OtherTherapeutic play

    Before the ultrasound examination, the children were introduced to the handmade amigurumi materials and shown how to use them as part of the therapeutic play intervention. They were then encouraged to engage in therapeutic play during the ultrasound examination.

06

What researchers measure

Primary outcomes

  1. assessing fear during ultrasound examination

    Children's Fear Scale: The scale was developed by McMurtry et al. to find out the anxiety levels of children between 4 and 10 years of age .There are five face pictures in the scale. Anxiety level is scored between "0 and 4". 0 indicates "no anxiety", while a scared face is scored 4 and indicates "too much anxiety". After the ultrasound examination ended, a researcher and parents filled Children's Fear Scale separately and independently to find out fear experienced by the child during the procedure.

    Time frame: 5 minutes

Secondary outcomes

  1. assessing anxiety during ultrasound examination

    Children's Anxiety Scale-State Anxiety was developed by Ersig et al. (2013); the Turkish validity and reliability study was conducted by Gerçeker et al. (2018). The scale is used to evaluate the levels of state anxiety in children aged 4-10. The scale, which is in the form of a thermometer, is rated on a scale where 0 means "calm, not tense or anxious" and 10 means "very tense or anxious." After theultrasound examination ended, a researcher and parents filled Children's Anxiety Scale separately and independently to find out fear experienced by the child during the procedure.

    Time frame: 5 minutes

07

Study locations

1 site
  • Fırat University
    Elâzığ, Elaziğ, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Feb 2026, 6 months.

Of 3,859 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 6 months is below that.

Counting every sponsor, half of 3,962 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 16, 2026
StartActual
Aug 3, 2025
Primary completionActual
Feb 3, 2026
CompletionActual
Feb 15, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938970
Lead sponsor
Firat University
Responsible party
DİDEM COŞKUN ŞİMŞEK (Principal Investigator, Firat University) — Principal investigator
First posted
Nov 16, 2026
Start date
Aug 3, 2025
Primary completion
Feb 3, 2026
Completion
Feb 15, 2026
Last update
Nov 16, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion